Gujarat Kidney & Super Speciality IPO Details
| Detail | Description |
|---|---|
| IPO Date | 22 to 24 Dec, 2025 |
| Listing Date | [.] |
| Face Value | ₹ 2 per share |
| Issue Price Band | ₹ 108 to ₹ 114 |
| Lot Size | 128 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 2,20,00,000 shares (agg. up to ₹ 250.80 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,68,43,250 shares |
| Share Holding Post Issue | 7,88,43,250 shares |
About Gujarat Kidney & Super Speciality IPO
Gujarat Kidney IPO is a book-building issue of ₹250.80 cr, which is entirely a fresh issue. The IPO price band is set at ₹108 to ₹114 per share and the minimum amount of investment required by an individual investor is ₹14,592 (128 shares), which will be listed on the platforms BSE, NSE with a tentative listing date. The lot size for an application is 128. The IPO subscription will open on December 22, 2025 and closes on December 24, 2025.
Company Background
Gujarat Kidney and Super Speciality Ltd. was incorporated in 2019. It is a leading healthcare central region in Gujarat, offering comprehensive multispeciality services across secondary and tertiary care. The company operates seven hospitals and four pharmacies, with a total bed capacity of 490, supporting advanced medical care across Vadodara, Godhra, Bharuch, Borsad and Anand. These hospitals provide a wide range of services, including general and surgical treatments, super speciality procedures, orthopaedics, joint replacement, obstetrics and gynaecology, cardiology and diabetology. As of June 30, 2025, their team comprised 89 doctors, 332 nurses and 338 support staff, delivering high-quality patient care across multiple locations.
Operations and Product Range
Facility and Production
They operate multispeciality hospitals and pharmacies across Gujarat, with a total bed capacity of 490 (340 operational). The facilities provide secondary and tertiary care, including super-speciality surgeries, orthopaedics, cardiology, joint replacement, and obstetrics. Supported by 89 doctors, 332 nurses, and 338 staff, the hospitals ensure high-quality patient care.
Brands and Market Presence
This company has established a strong presence in Gujarat’s healthcare sector through its seven hospitals and four pharmacies. Operating under well-recognised names like Gujarat Kidney and Superspeciality Hospital and Ashwini Medical Centre, the company delivers trusted secondary and tertiary care, building a reputable brand across multiple cities and enhancing accessibility to quality healthcare.
Revenue Channels
- • Fee from the patient care service, including general and speciality surgery treatment.
- • Fees from diagnostic and laboratory services.
- • Sale revenue through company-operated pharmacies.
Management and Shareholding
Promoters and Shareholding
The promoters and shareholders are experienced healthcare professionals and business leaders committed to expanding quality healthcare services in Gujarat. The promoters hold a significant stake in the company, ensuring strategic control and long-term vision, while the remaining shareholding may include institutional investors, private investors and other stakeholders supporting the company’s growth and operations.
Board Members
The board members of this company comprise experienced professionals from healthcare, management, and finance domains. They provide strategic guidance, oversee corporate governance and drive the company’s growth and operational excellence. Also, the promoters, along with independent directors who ensure compliance, transparency and sustainable development across all hospital and pharmacy operations.
Gujarat Kidney IPO Proceeds
- • Proceeds will be used for repayment of the debt and part-payment of the purchase consideration of the company.
- • Funding of capital expenditure requirements of the company’s new projects.
- • Investment in new technology equipment.
- • General Corporate Purposes.
Conclusion
The Gujarat Kidney and Super Speciality IPO offers an opportunity for investors to participate in a growing company within the healthcare sector. With a strong presence across multiple cities in Gujarat, a diversified revenue model and a focus on secondary and tertiary care. This company combines operational strength with growth potential. The company’s robust infrastructure, experienced management, and strategic expansion plans position it well to capitalise on increasing healthcare demand, making it an attractive investment option for those seeking exposure to India’s expanding healthcare industry.
Gujarat Kidney & Super Speciality IPO Financial Information
Latest Revenue
15.27
₹ Crore
Profit After Tax
5.40
₹ Crore
Net Worth
30.56
₹ Crore
Total Borrowing
4.03
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 2025 | 61.59 | 15.27 | 5.40 | 30.56 | 4.03 | ||||
| 31 Mar 2025 | 55.34 | 40.40 | 9.50 | 25.71 | 3.88 | ||||
| 31 Mar 2024 | 20.53 | 5.48 | 1.71 | 10.80 | 1.94 | ||||
| 31 Mar 2023 | 3.87 | 0.00 | -0.01 | 0.37 | — | ||||
| Amount in ₹ Crore | |||||||||
Gujarat Kidney & Super Speciality Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt/Equity | 0.15 |
| RoNW | 36.61% |
| PAT Margin | 23.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.85 | 2.74 |
| P/E (x) | 61.62 | 41.59 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Super speciality in urology with preeminence in renal sciences.
Light business model in the central region of Gujarat and a track record of performance and growth.
Experienced & Specialised team of doctors and nurses.
7 multispeciality hospitals and 4 pharmacies in India.
Download regulatory filings
Gujarat Kidney & Super Speciality IPO Timeline
| IPO Open Date | Mon, Dec 22, 2025 |
| IPO Close Date | Wed, Dec 24, 2025 |
| Tentative Allotment | Fri, Dec 26, 2025 |
| Initiation of Refunds | Mon, Dec 29, 2025 |
| Credit of Shares to Demat | Mon, Dec 29, 2025 |
| Tentative Listing Date | Tue, Dec 30, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Dec 24, 2025 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | 128 | ₹14,592 |
| Individual investors (Retail) (Max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (Min) | 14 | 1,792 | ₹2,04,288 |
| S-HNI (Max) | 68 | 8,704 | ₹9,92,256 |
| B-HNI (Min) | 69 | 8,832 | ₹10,06,848 |